HYPERKALAEMIA
Clinical trials for HYPERKALAEMIA explained in plain language.
Never miss a new study
Get alerted when new HYPERKALAEMIA trials appear
Sign up with your email to follow new studies for HYPERKALAEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study: can a simple powder keep kidney patients out of the ER?
Disease control CompletedThis study looked at whether continuing a drug called sodium zirconium cyclosilicate (Lokelma) after hospital discharge helps people with chronic kidney disease maintain normal potassium levels. 186 hospitalized patients were randomly assigned to either continue the drug or recei…
Matched conditions: HYPERKALAEMIA
Phase: PHASE4 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Spanish hospitals track Real-World use of potassium drug
Knowledge-focused CompletedThis study looked at how doctors in 20 Spanish hospitals use the drug Lokelma to treat patients with high potassium levels (hyperkalemia). Researchers collected information from 232 patients' medical records to understand how the drug is prescribed and how patients respond in rea…
Matched conditions: HYPERKALAEMIA
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Greek study tracks Real-World use of potassium drug in kidney and heart patients
Knowledge-focused CompletedThis completed study in Greece observed 125 patients with chronic kidney disease (on or off dialysis) or heart failure who were taking sodium zirconium cyclosilicate for high potassium levels. Researchers collected data on patient characteristics and treatment patterns over six m…
Matched conditions: HYPERKALAEMIA
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC